H

Huakang Biomedical Holdings Co Ltd
HKEX:8622

Watchlist Manager
Huakang Biomedical Holdings Co Ltd
HKEX:8622
Watchlist
Price: 0.176 HKD 7.32% Market Closed
Market Cap: 88.1m HKD
Have any thoughts about
Huakang Biomedical Holdings Co Ltd?
Write Note

Huakang Biomedical Holdings Co Ltd
Investor Relations

Huakang Biomedical Holdings Co. Ltd. operates as a medical group company. The company employs 83 full-time employees The company went IPO on 2018-12-13. The IVD reagents include male fertility IVD reagents, Epstein-Barr virus antibody detection reagents ad parasite antibody detection reagents, among others. The male fertility IVD reagents include sperm function test products, accessory genital glands test products, anti-sperm antibody test products, as well as male reproductive tract infection test products, among others. In addition, the Company is also involved in the sale of auxiliary reproductive supplies and equipments, such as glass coverslips and sperm sample collection cups.

Show more

Earnings Calls

No Earnings Calls Available

Management

Mr. Shuguang Zhang
Chairman of the Board
No Bio Available
Mr. Chunguang Zhang
CEO & Executive Director
No Bio Available
Mr. Lai Yin Poon CPA (Aust.), CPA (HKICPA)
CFO, Compliance Officer & Executive Director
No Bio Available
Mr. Jiaming He
Business Development Director & Executive Director
No Bio Available
Mr. Lai Ki Chau
Financial Controller & Company Secretary
No Bio Available

Contacts

Address
3/F, Effectual Building, 16 Hennessy Road, Wanchai
Contacts